john123321
New Member
for anyone in this thread got access to scientific articles unblocked or whatever
pubmed.ncbi.nlm.nih.gov
e2 62% Max reduction
pubmed.ncbi.nlm.nih.gov
2 weeks for e2 to return to normal IN WOMEN, should be shorter time period in men ofc
Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males - PubMed
Suppression of estrogen, via estrogen receptor or aromatase blockade, is being investigated in the treatment of different conditions. Exemestane (Aromasin) is a potent and selective irreversible aromatase inhibitor. To characterize its suppression of estrogen and its pharmacokinetic (PK)...
[Phase I single-dose administration study of exemestane in postmenopausal women] - PubMed
A single-dose administration study of a new type of aromatase inactivator, exemestane, was performed in normal healthy postmenopausal Japanese women. The study was conducted to investigate the safety, effect on serum and urinary estrogen concentrations, and pharmacokinetics of exemestane at 25...
